November 2014 - The Reporter
Many Americans say they want to “make sure the shot is safe” before getting vaccinated. That data is already in, says Paul Goepfert, M.D., and vaccine experts are confident that there won't be long-term side effects.
Published in Be Healthy

Employee engagement is an ongoing priority, and UAB leadership will continue to explore new ways to seek input and feedback as campus life and operations return to pre-COVID levels.

Published in Campus News

Sally Cramer and Stacy Moak from the College of Arts and Sciences partnered to lead a unique course that challenged graphic design students to conceive, design and prototype mobile apps that alleviate barriers to reentry.

Published in Teaching & Learning

Demolition will begin later this year on the Roy R. Kracke Clinical Services Building, one of the oldest buildings on campus, to make way the new Altec Styslinger Genomic Medicine and Data Sciences Building. Both the building and the man for whom it’s named, the first dean of the medical school, have a storied history.

Published in Campus News
Staff in all campus schools and units in workgroup A will continue to use UAB's standard process and timeframe for annual performance evaluations. The performance management app opens for use July 1 and must be completed by Sept. 30.
Published in Benefits & Policies
The online program is the perfect fit for UAB Police Sgt. Aleisha Dorning, who wants to create a mental health resource for law enforcement officers. UAB employees such as Dorning comprise about 30% of the program's students.
Published in Programs & Curricula
If you are 18 years of age or older and currently taking the blood thinners Xarelto (rivaroxaban) or Eliquis (apixaban), you may be eligible to participate in a research study. This study is being done to determine how your kidney function affects how you metabolize Xarelto or Eliquis. The study involves keeping a medication log for one week and one (12 hour) visit to UAB where we will collect blood samples at different times during the day. Participants will be compensated $150 for completing the one-day study visit. If you are interested or for more information, please contact our research team at pkpdstudy@uabmc.eduor 205-917-9800.
Published in Clinical Trials
You may be eligible to participate in a research study about the effects of Sacubitril/Valsartan on how your body handles insulin and glucose. This medication is related to the heart. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking sacubitril/valsartan or valsartan, and collecting blood samples. Participants will be compensated. Please e-mail Dr. Vibhu Parcha, vparcha@uabmc.edu if you are interested. 
Published in Clinical Trials
You may be eligible to participate in a research study about the effects of exercise and Metoprolol, a blood pressure pill, on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasian with no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please email Dr. Vibhu Parcha at vparcha@uabmc.edu if you are interested.
Published in Clinical Trials

The RECOVER study will investigate the use of Vagus Nerve Stimulation (VNS) Therapy in up to 1,000 people across the United States. To join the RECOVER study you must be 18 years or older and: currently depressed, have bi-polar depression that has lasted for at least two years or recurred several times, and have tried at least four types of antidepressant treatments and not found them helpful. Please leave a voice message at (205) 975-0068 or email candacegreen@uabmc.edu for more information.

Published in Clinical Trials
Page 70 of 351